# Choriogonadotropin alfa

## Ovidrel inj 250mcg

| TAH Drug Code      | [IOVI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IOVI)                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Women undergoing superovulation prior to assisted reproductive techniques such as in-vitro fertilisation (IVF) ,Anovulatory or oligo-ovulatory women                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Women undergoing superovulation prior to assisted reproductive techniques such as in-vitro fertilisation (IVF) 250 mcg SC 24-48 hr after the last administration of an FSH or hMG prep, when optimal stimulation of follicular growth is achieved Anovulatory or oligo-ovulatory women 250 mcg SC 24-48 hr after optimal stimulation of follicular growth is achieved. The patient is recommended to have coitus on the day of, & the day after inj.                             |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypothalamic & pituitary tumours; ovarian enlargement or cyst due to reasons other than polycystic ovarian disease; gynaecological haemorrhage of unknown aetiology; ovarian, uterine or mammary carcinoma; extrauterine pregnancy in the previous 3 months; active thromboembolic disorders; primary ovarian failure, sexual organ malformations incompatible with pregnancy; fibroid uterine tumours incompatible with pregnancy; postmenopausal women. Pregnancy & lactation. |
| Adverse Effects    | Local inj site reactions, headache, fatigue, GI disturbances, mild or moderate ovarian hyperstimulation syndrome. Ectopic pregnancy, ovarian torsion & other complications in some patients after hCG administration. Uncommonly, depression, irritability, restlessness, diarrhoea, severe ovarian hyperstimulation syndrome, breast pain. Rarely, thromboembolism.                                                                                                             |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/choriogonadotropin-alfa-drug-information)                                                                                                                                                                                                                                                                                                                                                                                           |

